Viewing Study NCT06957561

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:04 PM
Ignite Modification Date: 2026-01-22 @ 9:24 PM
Study NCT ID: NCT06957561
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-04
First Post: 2025-04-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Sponsor: Sun Yat-sen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Cancer View
None Muscle-invasive Bladder Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cisplatin-Ineligible View
None Muscle-invasive bladder cancer View
None Disitamab Vedotin View
None Ivonescimab View
None Perioperative treatment View